ICU Medical (ICUI) Tops Q1 EPS by 13c, Reaffirms Guidance

ICU Medical (NASDAQ: ICUI) reported Q1 EPS of $1.14, $0.13 better than the analyst estimate of $1.01. Revenue for the quarter came in at $89.9 million versus the consensus estimate of $88.04 million.

Fiscal Year 2016 Guidance

For the year, the Company is reiterating its 2016 guidance. It expects revenue to be in the range of $355 million to $365 million; adjusted diluted earnings per share to be in the range of $4.34 to $4.46, and adjusted EBITDA to be in the range of $123 million to $127 million.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.

You May Also Be Interested In

• Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
• SLM (SLM) Misses Q3 EPS by 36c; lowers guidance
• Accenture shares fall on insider sales and analyst downgrade